This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at firstname.lastname@example.org or call 800-767-3771 ext. 9339.
For Immediate Release
Chicago, IL – January 6, 2012 – Zacks Equity Research highlights AGCO Corporation (AGCO - Analyst Report) as the Bull of the Day and Urban Outfitters (URBN - Analyst Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Monsanto Company (MON - Analyst Report), Syngenta AG (SYT - Analyst Report) and The Dow Chemical Company (DOW - Analyst Report).
Full analysis of all these stocks is available at http://at.zacks.com/?id=2678.
Here is a synopsis of all five stocks:
Bull of the Day:
Driven by strong global demand for agricultural equipment, AGCO Corporation (AGCO - Analyst Report) reported third quarter EPS of $0.87 versus $0.66 in the year-earlier quarter, surpassing the Zacks Consensus Estimate of $0.75. For fiscal 2011, AGCO expects EPS of $4.30.
Global industry sales are anticipated to grow in 2011. With a full product line of farm equipment and a wide network of dealers and distributors, we believe AGCO is well positioned over the long term to capitalize on the need for increased food production, which is being driven by worldwide population growth.
Moreover, the company is also looking to expand operations in high-growth emerging markets, which bode well for future operating performance. We maintain our Outperform recommendation with a target price of $51.00, based on a P/E of 11.7 and our fiscal 2011 earnings estimate.
Bear of the Day:
We are initiating the coverage on Urban Outfitters (URBN - Analyst Report) with an Underperform recommendation. Despite registering growth of 6.3% in the top line, the company's third-quarter 2012 earnings of $0.33 per share fell 23.3% from the prior-year quarter due to the rise in cost of sales and SG&A expenses.
The company's inventory level, which rose 27%, remains a matter of concern. The company, in order to clear its inventory, is selling the slow-moving stock of women's clothing at increased markdowns, which in turn, is weighing upon margins. Its gross margin contracted 571 basis points to 35.4% during the quarter.
Management now expects the fourth quarter gross margin to be lower than the third quarter. Fashion obsolescence remains the key issue for the company's business model. In the past, this has weighed down on the company s comparable-store sales and operating margins. The company is presently inflicted with the same fashion risk.
Latest Posts on the Zacks Analyst Blog:
Monsanto Beats, Guides High
Monsanto Company (MON - Analyst Report) posted a strong financial result in the first quarter of fiscal 2012 with an EPS (excluding restructuring expense) of 23 cents, breezing past a meager 2 cents recorded a year ago. The result exceeded the Zacks Consensus Estimate of 19 cents.
The company generated revenues of $2,439 million, up from $1,836 million registered in the year-ago quarter. The revenue exceeded the Zacks Consensus Estimate of $2,034 million based on improved sales in the growing Latin America market.
Management affirmed its free cash flow guidance for fiscal 2012 in the range of $1.3 billion to $1.5 billion, reflecting an investment of $600 to $700 million in capital expenditures.
For fiscal 2012, the company expects net cash provided by operating activities to be $2.2 billion to $2.5 billion, and net cash required by investing activities to be approximately $900 million to $1 billion.
The company guided high on full-year 2012 ongoing EPS, expecting to achieve $3.39 to $3.44 of ongoing and as-reported EPS.
Going forward, a strong US Order book coupled with a pipeline of advanced R&D appears to add momentum to the stock.
During early December 2011, Monsanto Company declared a quarterly dividend on its common stock of $0.30 per share. The dividend will be payable on January 27, 2012 to shareowners of record as of January 6, 2012.
Monsanto Company is a leading global provider of agricultural products for farmers, operating in Seeds and Genomics and Agricultural Productivity segments. Monsanto’s biotechnology research and innovations position it as a market leader above its peers, such as Syngenta AG (SYT - Analyst Report) and The Dow Chemical Company (DOW - Analyst Report).
We currently maintain a long-term Outperform recommendation on the stock. Monsanto has a Zacks #2 Rank, which translates into a short-term Buy rating (1-3 months).
Get the full analysis of all these stocks by going to http://at.zacks.com/?id=2649.
About the Bull and Bear of the Day
Every day, the analysts at Zacks Equity Research select two stocks that are likely to outperform (Bull) or underperform (Bear) the markets over the next 3-6 months.
About the Analyst Blog
Updated throughout every trading day, the Analyst Blog provides analysis from Zacks Equity Research about the latest news and events impacting stocks and the financial markets.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous analyst coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today by visiting http://at.zacks.com/?id=7158.
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD from MIT Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment
Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=4582.
Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Follow us on Twitter: http://twitter.com/zacksresearch
Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
Zacks Investment Research
800-767-3771 ext. 9339